Hostname: page-component-669899f699-cf6xr Total loading time: 0 Render date: 2025-04-26T01:47:22.367Z Has data issue: false hasContentIssue false
  • English
  • Français

Biomarkers of neurodegeneration among patients with very late-onset schizophrenia-like psychosis: future implications

Commentary on “Characteristics of very late-onset schizophrenia-like psychosis classified with the biomarkers for Alzheimer’s disease: a retrospective cross-sectional study” by Satake et al.

Published online by Cambridge University Press:  14 December 2022

Corinne E. Fischer
Corinne E. Fischer*
Affiliation:
Keenan Research Centre for Biomedical Science, St. Michael’s Hospital, Toronto, ON, Canada Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada
*
Email: [email protected]
Get access

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Commentary
Information
International Psychogeriatrics , Volume 36 , Special Issue 1: Issue Theme: Schizophrenia and Other Psychotic Disorders in Later Life , January 2024 , pp. 24 - 27
Copyright
© International Psychogeriatric Association, 2022

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Agüera-Ortiz, L. et al. (2022). Psychosis as a treatment target in dementia: a roadmap for designing interventions. J Alzheimers Dis, 88, 1203–1228.Google Scholar
Almeida, O. P., Ford, A. H., Hankey, G. J., Yeap, B. B., Golledge, J. and Flicker, L. (2019). Risk of dementia associated with psychotic disorders in later life: the health in men study (Hims). Psychol Med, 49, 232–242.Google Scholar
Cai, L. and Huang, J. (2018). Schizophrenia and risk of dementia: a meta-analysis study. Neuropsychiatr Dis Treat, 14, 2047–2055.Google Scholar
Cummings, J. et al. (2020). Criteria for psychosis in major and mild neurocognitive disorders: International Psychogeriatric Association (IPA) consensus clinical and research definition. Am J Geriatr Psychiatry, 28, 1256–1269.Google Scholar
Fischer, C. E. et al. (2020). Revisiting criteria for psychosis in Alzheimer’s Disease and related dementias: toward better phenotypic classification and biomarker research. J Alzheimer’s Dis, 73, 1143–1156.Google Scholar
Howard, R., Rabins, P. V., Seeman, M. V. and Jeste, D. V. (2000). Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus. The International Late-Onset Schizophrenia Group. Am J Psychiatry, 157, 172–178.Google Scholar
Ismail, Z. et al. (2016). Neuropsychiatric symptoms as early manifestations of emergent dementia: provisional diagnostic criteria for mild behavioral impairment. Alzheimer’s Dement, 12, 195–202.Google Scholar
Jeste, D. V. and Finkel, S. I. (2000). Psychosis of Alzheimer’s disease and related dementias: diagnostic criteria for a distinct syndrome. Am J Geriatric Psychiatry, 8, 29–34.Google Scholar
Kales, H. C. et al. (2007). Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications. Am J Psychiatry, 164, 1568–1576, Quiz 1623.Google Scholar
Kanemoto, H. et al. (2022). Characteristics of very late-onset schizophrenia-like psychosis as prodromal dementia with lewy bodies: a cross-sectional study. Alzheimers Res Ther, 14, 137.Google Scholar
Naasan, G. et al. (2021). Psychosis in neurodegenerative disease: differential patterns of hallucination and delusion symptoms. Brain, 144, 999–1012.Google Scholar
Nagendra, J. and Snowdon, J. (2020). An Australian study of delusional disorder in late life. Int Psychogeriatr, 32, 453–462.Google Scholar
Paquet, C. et al. (2016). Utility of CSF biomarkers in psychiatric disorders: a national multicentre prospective study. Alzheimer’s Res Ther, 8, 27.Google Scholar
Ropacki, S. A. and Jeste, D. V. (2005). Epidemiology of and risk factors for psychosis of Alzheimer’s disease: a review of 55 studies published from 1990 to 2003. Am J Psychiatry, 162, 2022–2030.Google Scholar
Satake, Y. et al. (2021). Case report: usefulness of biomarkers for Alzheimer’s disease in two cases with very-late-onset schizophrenia-like psychosis. Front Psychiatry, 12, 742659.Google Scholar
Satake, Y. et al. (2022). Characteristics of very late-onset schizophrenia-like psychosis classified with the biomarkers for Alzheimer’s disease: a retrospective cross-sectional study. Int Psychogeriatr, To be published.Google Scholar
Schuster, J.-P., Hoertel, N., Von Gunten, A., Seigneurie, A.-S. and Limosin, F. (2020). Benzodiazepine use among older adults with schizophrenia spectrum disorder: prevalence and associated factors in a multicenter study. Int Psychogeriatr, 32, 441–451.Google Scholar
Tripathi, A., Kar, S. K. and Shukla, R. (2018). Cognitive deficits in schizophrenia: understanding the biological correlates and remediation strategies. Clin Psychopharmacol Neurosci, 16, 7–17.Google Scholar
Valcic, M. et al. (2022). Determining whether sex and zygosity modulates the association between APOE4 and psychosis in a neuropathologically-confirmed Alzheimer’s disease cohort. Brain Sci, 12, 1266.Google Scholar
Yokoi, Y., Takano, H., Sakata, M., Maruo, K., Nakagome, K. and Matsuda, H. (2019). Discrete effect of each mild behavioural impairment category on dementia conversion or cognitive decline in patients with mild cognitive impairment. Psychogeriatrics, 19, 591–600.Google Scholar